Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.

Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C.

EMBO Mol Med. 2018 Sep 17. pii: e9316. doi: 10.15252/emmm.201809316. [Epub ahead of print]

2.

Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer-related pain during daily application of lidocaine-prilocaine cream (EMLA™) for 10 days.

Effendy I, Gelber A, Lehmann P, Huledal G, Lillieborg S.

Br J Dermatol. 2015 Jul;173(1):259-61. doi: 10.1111/bjd.13605. Epub 2015 May 12. No abstract available.

PMID:
25494699
3.

Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers.

Quartino A, Huledal G, Sparve E, Lüttgen M, Bueters T, Karlsson P, Olsson T, Paraskos J, Maltby J, Claeson-Bohnstedt K, Lee CM, Alexander R, Fälting J, Paulsson B.

Clin Pharmacol Drug Dev. 2014 Sep;3(5):396-405. doi: 10.1002/cpdd.130. Epub 2014 May 26.

PMID:
27129013
4.

Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers.

Boström E, Bohnstedt KC, Jostell KG, Alverlind S, Huledal G, Paulsson B, Hårdemark HG, Öhd J, Lindholm S.

Clin Pharmacol Drug Dev. 2014 Jan;3(1):63-71. doi: 10.1002/cpdd.59. Epub 2013 Sep 9.

PMID:
27128232
5.

Stable plasma concentrations of unbound ropivacaine during postoperative epidural infusion for 24-72 hours in children.

Berde CB, Yaster M, Meretoja O, McCann ME, Huledal G, Gustafsson U, Larsson LE.

Eur J Anaesthesiol. 2008 May;25(5):410-7. doi: 10.1017/S0265021507003146. Epub 2008 Jan 21.

PMID:
18205962
6.

The effect of a long term epidural infusion of ropivacaine on CYP2D6 activity.

Wink J, Veering BT, Kruit M, Burm AG, Huledal GA, Ekström GY, Stienstra R, van Kleef JW.

Anesth Analg. 2008 Jan;106(1):143-6, table of contents. doi: 10.1213/01.ane.0000297293.84075.74.

PMID:
18165569
7.

A study of organic acid transporter mediated pharmacokinetic interaction between NXY-059 and cefuroxime.

Kågedal M, Nilsson D, Huledal G, Reinholdsson I, Cheng YF, Asenblad N, Pekar D, Borgå O.

J Clin Pharmacol. 2007 Aug;47(8):1043-8. No abstract available.

PMID:
17660486
8.

Effect of NXY-059, a novel neuroprotectant, on the pharmacokinetics of a single dose of digoxin in healthy subjects.

Huledal G, Nilsson D, Kågedal M, Reinholdsson I, Cheng YF, Svensson H, Borgå O, van Hout M.

Curr Med Res Opin. 2007 Jul;23(7):1531-9.

PMID:
17559748
9.

Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants.

Bösenberg AT, Thomas J, Cronje L, Lopez T, Crean PM, Gustafsson U, Huledal G, Larsson LE.

Paediatr Anaesth. 2005 Sep;15(9):739-49.

PMID:
16101704
10.

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.

Huledal G, Jonzon B, Malmenäs M, Hedman A, Andersson LI, Odlind B, Brater DC.

Clin Pharmacol Ther. 2005 May;77(5):437-50.

PMID:
15900289
11.

Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.

Rapp HJ, Molnár V, Austin S, Krohn S, Gädeke V, Motsch J, Boos K, Williams DG, Gustafsson U, Huledal G, Larsson LE.

Paediatr Anaesth. 2004 Sep;14(9):724-32.

PMID:
15330953
12.
13.

Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery.

Ekatodramis G, Borgeat A, Huledal G, Jeppsson L, Westman L, Sjövall J.

Anesthesiology. 2003 Jan;98(1):143-50.

PMID:
12502990
14.

Plasma concentrations of ropivacaine following a single-shot caudal block of 1, 2 or 3 mg/kg in children.

Bösenberg AT, Thomas J, Lopez T, Huledal G, Jeppsson L, Larsson LE.

Acta Anaesthesiol Scand. 2001 Nov;45(10):1276-80.

PMID:
11736682
15.

Pharmacokinetics and analgesic effect of ropivacaine following ilioinguinal/iliohypogastric nerve block in children.

Dalens B, Ecoffey C, Joly A, Giaufré E, Gustafsson U, Huledal G, Larsson LE.

Paediatr Anaesth. 2001 Jul;11(4):415-20.

PMID:
11442857
17.

Ropivacaine pharmacokinetics after caudal block in 1-8 year old children.

Lönnqvist PA, Westrin P, Larsson BA, Olsson GL, Lybeck A, Huledal G, Bielenstein M.

Br J Anaesth. 2000 Oct;85(4):506-11.

18.

EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study.

Lok C, Paul C, Amblard P, Bessis D, Debure C, Faivre B, Guillot B, Ortonne JP, Huledal G, Kalis B.

J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):208-13.

PMID:
10025747

Supplemental Content

Loading ...
Support Center